tiprankstipranks
Trending News
More News >
Insmed (INSM)
NASDAQ:INSM
US Market
Advertisement

Insmed (INSM) Technical Analysis

Compare
995 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Insmed’s (INSM) Moving Averages Convergence Divergence (MACD) indicator is 4.88, suggesting Insmed is a Buy.
Insmed’s (INSM) 20-Day exponential moving average is 160.29, while Insmed’s (INSM) share price is $166.95, making it a Buy.
Insmed’s (INSM) 50-Day exponential moving average is 148.30, while Insmed’s (INSM) share price is $166.95, making it a Buy.

Insmed (INSM) Pivot Points

Oct 30, 2025, 05:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
159.28
161.20
163.24
165.16
167.20
169.12
171.16
Fibonacci
161.20
162.71
163.64
165.16
166.67
167.60
169.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Insmed (INSM) Moving Averages

Oct 30, 2025, 05:24 PM
Period
Simple
Exponential
MA5
163.21Buy
164.53Buy
MA10
163.86Buy
163.42Buy
MA20
162.33Buy
160.29Buy
MA50
149.50Buy
148.30Buy
MA100
127.11Buy
130.96Buy
MA200
100.46Buy
108.34Buy
Insmed’s (INSM) 10-Day exponential moving average is 163.42, while Insmed’s (INSM) share price is $166.95, making it a Buy.
Insmed’s (INSM) 100-Day exponential moving average is 130.96, while Insmed’s (INSM) share price is $166.95, making it a Buy.
Insmed’s (INSM) stock price is $166.95 and Insmed’s (INSM) 50-day simple moving average is 149.50, creating a Buy signal.
Insmed’s (INSM) stock price is $166.95 and Insmed’s (INSM) 100-day simple moving average is 127.11, creating a Buy signal.
Insmed’s (INSM) stock price is $166.95 and Insmed’s (INSM) 200-day simple moving average is 100.46, creating a Buy signal.

Insmed (INSM) Technical Indicators

Oct 30, 2025, 05:24 PM
Name
Value
Implied Action
RSI (14)
66.28
Neutral
STOCH (9,6)
79.18
Neutral
STOCHRSI (14)
79.18
Neutral
MACD (12,26)
4.88
Buy
ADX (14)
37.46
Neutral
Williams %R
-9.42
Sell
CCI (14)
101.85
Sell
ATR (14)
4.44
-
Ultimate Oscillator
56.80
Neutral
ROC
1.55
Buy
Insmed’s (INSM) Relative Strength Index (RSI) is 66.28, creating a Neutral signal.
Insmed’s (INSM) Trend Strength Indicator (ADX) is 37.46, creating a Neutral signal.
Insmed’s (INSM) Commodity Channel Index (CCI) is 101.85, creating a Sell signal.
Insmed’s (INSM) Price Rate of Change (ROC) is 1.55, creating a Buy signal.

FAQ

Is INSM a Buy, Hold, or Sell?
Based on INSM’s technical indicators, INSM is a Strong Buy.
    What is INSM’s RSI (14)?
    INSM’s RSI (14) is 66.28, which suggests INSM is a Neutral.
      What is INSM’s MACD?
      INSM’s MACD is 4.88, which suggests INSM is a Buy.
        What is INSM’s 5-day moving average?
        INSM’s 5-day moving average is 163.21, which suggests INSM is a Buy.
          What is INSM’s 20-day moving average?
          INSM 20-day moving average is 162.33, which suggests INSM is a Buy.
            What is INSM’s 50-day moving average?
            INSM’s 50-day moving average is 149.50, which suggests INSM is a Buy.
              What is INSM’s 200-day moving average?
              INSM’s 200-day moving average is 100.46, which suggests INSM is a Buy.
                What is INSM’s Williams % R (14)?
                INSM’s Williams % R (14) is -9.42, which suggests INSM is a Sell.
                  What is INSM’s CCI (14)?
                  INSM’s CCI (14) is 101.85, which suggests INSM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis